Europe Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity

March 2022 | 137 pages | ID: EF4C3B285BC3EN
GMD Research

Abstracts

Europe bioanalytical testing services market was valued at $ 806.6 million in 2021 and will grow by 9.0% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

Highlighted with 39 tables and 79 figures, this 137-page report “Europe Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country.

Based on Molecule Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Small Molecules
• Large Molecules
• LC-MS Studies
• Immunoassays
• Other Large Molecule Tests

Based Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Bioavailability and Bioequivalence Studies
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Absorption, Distribution, Metabolism, Excretion (ADME)
• Other Applications

By Test Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Cell-based Assays
• Bacterial Cell-based Assays
• Viral Cell-based Assays
• Virology Testing
• In Vitro Virology Testing
• In Vivo Virology Testing
• Species-Specific Viral PCR Assays
• Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
• Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
• Viral Serology, Immunogenicity, and Neutralizing Antibodies
• Method Development Optimization and Validation (MDOV)
• Biomarker Testing
• Pharmacokinetic Testing
• Other Test Types

By Workflow Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Sample Preparation
• Protein Precipitation
• Liquid-liquid Extraction (LLE)
• Sample Analysis
• Hyphenated Technique
• Chromatographic Technique
• Electrophoresis
• Ligand Binding Assay
• Mass Spectrometry
• Nuclear Magnetic Resonance
• Other Workflow Processes

By Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Therapeutic Areas

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharma and Biopharma Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Contract Research Organizations (CROs)

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Charles River Laboratories International Inc.
• Covance Inc.
• Eurofins Scientific
• ICON PLC
• Intertek Group PLC
• IQVIA Holdings, Inc.
• Laboratory Corporation of America Holdings
• Medpace Holdings, Inc.
• Pace Analytical Services LLC.
• Parexel International Corporation
• PPD Inc.
• SGS SA
• Syneos Health, LLC
• Toxikon Corporation
• WuXi Apptech Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY MOLECULE TYPE

3.1 Market Overview by Molecule Type
3.2 Small Molecules
3.3 Large Molecules
  3.3.1 LC-MS Studies
  3.3.2 Immunoassays
  3.3.3 Other Large Molecule Tests

4 SEGMENTATION OF EUROPE MARKET BY APPLICATION

4.1 Market Overview by Application
4.2 Bioavailability and Bioequivalence Studies
4.3 Pharmacokinetics (PK)
4.4 Pharmacodynamics (PD)
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)
4.6 Other Applications

5 SEGMENTATION OF EUROPE MARKET BY TEST TYPE

5.1 Market Overview by Test Type
5.2 Cell-based Assays
  5.2.1 Bacterial Cell-based Assays
  5.2.2 Viral Cell-based Assays
5.3 Virology Testing
  5.3.1 In Vitro Virology Testing
  5.3.2 In Vivo Virology Testing
  5.3.3 Species-Specific Viral PCR Assays
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
  5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
  5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies
5.5 Method Development Optimization and Validation (MDOV)
5.6 Biomarker Testing
5.7 Pharmacokinetic Testing
5.8 Other Test Types

6 SEGMENTATION OF EUROPE MARKET BY WORKFLOW PROCESS

6.1 Market Overview by Workflow Process
6.2 Sample Preparation
  6.2.1 Protein Precipitation
  6.2.2 Liquid-liquid Extraction (LLE)
  6.2.3 Solid Phase Extraction (SPE)
6.3 Sample Analysis
  6.3.1 Hyphenated Technique
  6.3.2 Chromatographic Technique
  6.3.3 Electrophoresis
  6.3.4 Ligand Binding Assay
  6.3.5 Mass Spectrometry
  6.3.6 Nuclear Magnetic Resonance
6.4 Other Workflow Processes

7 SEGMENTATION OF EUROPE MARKET BY THERAPEUTIC AREA

7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Neurology
7.4 Infectious Diseases
7.5 Gastroenterology
7.6 Cardiology
7.7 Other Therapeutic Areas

8 SEGMENTATION OF EUROPE MARKET BY END USER

8.1 Market Overview by End User
8.2 Pharma and Biopharma Companies
8.3 Contract Development and Manufacturing Organizations (CDMOs)
8.4 Contract Research Organizations (CROs)

9 EUROPEAN MARKET 2021-2031 BY COUNTRY

9.1 Overview of European Market
9.2 Germany
9.3 U.K.
9.4 France
9.5 Spain
9.6 Italy
9.7 Russia
9.8 Rest of European Market

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Europe Bioanalytical Testing Services Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in Europe Bioanalytical Testing Services Market
Table 5. Europe Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn
Table 6. Europe Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn
Table 7. Europe Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 8. Europe Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn
Table 9. Europe Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn
Table 10. Europe Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn
Table 11. Europe Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn
Table 12. Europe Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 13. Europe Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn
Table 14. Europe Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn
Table 15. Europe Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 16. Europe Bioanalytical Testing Services Market by End User, 2021-2031, $ mn
Table 17. Europe Bioanalytical Testing Services Market by Country, 2021-2031, $ mn
Table 18. Germany Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 19. Germany Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 20. Germany Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 21. U.K. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 22. U.K. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 23. U.K. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 24. France Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 25. France Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 26. France Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 27. Spain Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 28. Spain Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 29. Spain Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 30. Italy Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 31. Italy Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 32. Italy Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 33. Russia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 34. Russia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 35. Russia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 36. Bioanalytical Testing Services Market in Rest of Europe by Country, 2021-2031, $ mn
Table 37. Charles River Laboratories International Inc.: Company Snapshot
Table 38. Charles River Laboratories International Inc.: Business Segmentation
Table 39. Charles River Laboratories International Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Europe Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Leading Causes of Death in the World, 2019-2020, million
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Drivers and Impact Factors of Europe Bioanalytical Testing Services Market
Figure 10. Primary Restraints and Impact Factors of Europe Bioanalytical Testing Services Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Europe Bioanalytical Testing Services Market
Figure 13. Breakdown of Europe Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue
Figure 14. Europe Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%)
Figure 15. Europe Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn
Figure 16. Europe Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn
Figure 17. Europe Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn
Figure 18. Europe Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn
Figure 19. Europe Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn
Figure 20. Breakdown of Europe Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue
Figure 21. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 22. Europe Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn
Figure 23. Europe Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn
Figure 24. Europe Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn
Figure 25. Europe Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn
Figure 26. Europe Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn
Figure 27. Breakdown of Europe Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue
Figure 28. Europe Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)
Figure 29. Europe Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn
Figure 30. Europe Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn
Figure 31. Europe Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn
Figure 32. Europe Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn
Figure 33. Europe Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn
Figure 34. Europe Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn
Figure 35. Europe Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn
Figure 36. Europe Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn
Figure 37. Europe Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn
Figure 38. Europe Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn
Figure 39. Europe Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn
Figure 40. Europe Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn
Figure 41. Europe Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn
Figure 42. Europe Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn
Figure 43. Breakdown of Europe Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue
Figure 44. Europe Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%)
Figure 45. Europe Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn
Figure 46. Europe Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn
Figure 47. Europe Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn
Figure 48. Europe Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn
Figure 49. Europe Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn
Figure 50. Europe Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn
Figure 51. Europe Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn
Figure 52. Europe Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn
Figure 53. Europe Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn
Figure 54. Europe Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn
Figure 55. Europe Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn
Figure 56. Europe Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn
Figure 57. Breakdown of Europe Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue
Figure 58. Europe Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 59. Europe Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn
Figure 60. Europe Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn
Figure 61. Europe Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn
Figure 62. Europe Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn
Figure 63. Europe Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn
Figure 64. Europe Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn
Figure 65. Breakdown of Europe Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue
Figure 66. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 67. Europe Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn
Figure 68. Europe Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn
Figure 69. Europe Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 70. Breakdown of European Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue
Figure 71. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 72. Bioanalytical Testing Services Market in Germany, 2021-2031, $ mn
Figure 73. Bioanalytical Testing Services Market in U.K., 2021-2031, $ mn
Figure 74. Bioanalytical Testing Services Market in France, 2021-2031, $ mn
Figure 75. Bioanalytical Testing Services Market in Spain, 2021-2031, $ mn
Figure 76. Bioanalytical Testing Services Market in Italy, 2021-2031, $ mn
Figure 77. Bioanalytical Testing Services Market in Russia, 2021-2031, $ mn
Figure 78. Bioanalytical Testing Services Market in Rest of Europe, 2021-2031, $ mn
Figure 79. Growth Stage of Europe Bioanalytical Testing Services Industry over the Forecast Period